Literature DB >> 15694811

Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome.

Steven Rakita1, Mark Bloomston, Desiree Villadolid, Donald Thometz, Emmanuel Zervos, Alexander Rosemurgy.   

Abstract

The conventional wisdom is that inadvertent esophagotomy complicates laparoscopic Heller myotomy. This study was undertaken to determine if esophagotomy at myotomy can be predicted by preoperative therapy, and if esophagotomy and/or its repair jeopardizes outcomes. Of 222 laparoscopic Heller myotomies undertaken since 1992, inadvertent esophagotomy occurred in 16 patients (7%); 60 patients who underwent myotomy without esophagotomy were utilized for comparison. Dysphagia and reflux before/after myotomy were scored by patients on a Likert scale (0-5). The median (mean +/- SD) follow-up after myotomy with esophagotomy was 38.8 months (31.6 +/- 21.9 months) versus 46.3 months (51.0 +/- 21.2 months) after myotomy alone. All esophagotomies were immediately recognized and repaired. Patients who experienced esophagotomy were similar to those who did not in application of Botox (56% vs. 77%) or dilation (44% vs. 65%), years of dysphagia (7.3 +/- 5.4 vs. 7.4 +/- 6.0), and mean preoperative dysphagia score (4.9 +/- 0.4 vs. 4.8 +/- 0.4). Esophagotomy led to longer hospitalizations (5.2 days +/- 2.5 days vs. 1.5 days +/- 0.7 days, P < 0.05) but not different postoperative dysphagia scores (1.5 +/- 1.7 vs. 2.1 +/- 1.4), reflux scores (1.4 +/- 1.7 vs. 2.3 +/- 1.3), or good or excellent outcomes (86% vs 84%). Esophagotomy during laparoscopic Heller myotomy is infrequent and cannot be predicted by preoperative therapy or duration or severity of dysphagia. Furthermore, complications after esophagotomy are infrequent and outcomes are indistinguishable from those of patients undergoing uneventful myotomy.

Entities:  

Mesh:

Year:  2005        PMID: 15694811     DOI: 10.1016/j.gassur.2004.10.015

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  An antireflux procedure should not routinely be added to a Heller myotomy.

Authors:  W O Richards; K W Sharp; M D Holzman
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

2.  Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.

Authors:  M F Vaezi; J E Richter; C M Wilcox; P L Schroeder; S Birgisson; R L Slaughter; R E Koehler; M E Baker
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 3.  Pathophysiology of achalasia.

Authors:  I Hirano
Journal:  Curr Gastroenterol Rep       Date:  1999-06

4.  Videoscopic Heller myotomy for achalasia--results beyond short-term follow-up.

Authors:  M Bloomston; W Boyce; J Mamel; M Albrink; M Murr; A Durkin; A Rosemurgy
Journal:  J Surg Res       Date:  2000-08       Impact factor: 2.192

5.  Clinical and manometric effects of nifedipine in patients with esophageal achalasia.

Authors:  M Bortolotti; G Labò
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

Review 6.  Current therapies for achalasia: comparison and efficacy.

Authors:  M F Vaezi; J E Richter
Journal:  J Clin Gastroenterol       Date:  1998-07       Impact factor: 3.062

7.  Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation.

Authors:  M Gelfond; P Rozen; T Gilat
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

8.  Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change.

Authors:  Marco G Patti; Piero M Fisichella; Silvana Perretta; Carlos Galvani; Maria V Gorodner; Thomas Robinson; Lawrence W Way
Journal:  J Am Coll Surg       Date:  2003-05       Impact factor: 6.113

Review 9.  Comparison of forceful dilatation and esophagomyotomy in patients with achalasia of the esophagus.

Authors:  A Csendes; I Braghetto; P Burdiles; P Csendes
Journal:  Hepatogastroenterology       Date:  1991-12

10.  Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.

Authors:  V M Fishman; H P Parkman; T D Schiano; C Hills; M A Dabezies; S Cohen; R S Fisher; L S Miller
Journal:  Am J Gastroenterol       Date:  1996-09       Impact factor: 10.864

View more
  12 in total

1.  Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone.

Authors:  C Daniel Smith; Alessandro Stival; D Lee Howell; Vickie Swafford
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Prevention of post-operative leak following laparoscopic Heller myotomy.

Authors:  Kelly R Finan; David Renton; Catherine C Vick; Mary T Hawn
Journal:  J Gastrointest Surg       Date:  2008-09-10       Impact factor: 3.452

Review 3.  Surgical treatment for achalasia: when should it be performed, and for which patients?

Authors:  Hideyuki Kashiwagi; Nobuo Omura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

4.  BMI affects presenting symptoms of achalasia and outcome after Heller myotomy.

Authors:  S S Rakita; D Villadolid; C Kalipersad; D Thometz; A Rosemurgy
Journal:  Surg Endosc       Date:  2006-12-04       Impact factor: 4.584

5.  Laparoscopic Heller myotomy provides durable relief from achalasia and salvages failures after botox or dilation.

Authors:  Alexander Rosemurgy; Desiree Villadolid; Donald Thometz; Candice Kalipersad; Steven Rakita; Michael Albrink; Milton Johnson; Worth Boyce
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Impact of prior interventions on outcomes during per oral endoscopic myotomy.

Authors:  Brian E Louie; Andreas M Schneider; Drew B Schembre; Ralph W Aye
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

7.  Laparoscopic Heller myotomy for achalasia facilitated by robotic assistance.

Authors:  C Galvani; M V Gorodner; F Moser; M Baptista; P Donahue; S Horgan
Journal:  Surg Endosc       Date:  2006-05-13       Impact factor: 4.584

8.  Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention.

Authors:  Ahmed Sharata; Ashwin A Kurian; Christy M Dunst; Neil H Bhayani; Kevin M Reavis; Lee L Swanström
Journal:  J Gastrointest Surg       Date:  2013-04-23       Impact factor: 3.452

Review 9.  Meta-analysis of randomized and controlled treatment trials for achalasia.

Authors:  Lan Wang; You-Ming Li; Lan Li
Journal:  Dig Dis Sci       Date:  2008-12-24       Impact factor: 3.199

10.  Outcomes promote reoperative Heller myotomy for symptoms of achalasia.

Authors:  S Rakita; D Villadolid; C Kalipersad; D Thometz; A Rosemurgy
Journal:  Surg Endosc       Date:  2007-04-14       Impact factor: 3.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.